Daniel Abdun-Nabi, CEO at Emergent BioSolutions Inc. (EBS), sold 29,539 shares at $65.00 ($1.9M) on 2018-09-17, disclosed to the SEC on 2018-09-18.
Scheduled sale ($1.9M) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.00 | 28,220 | $1.8M | 95.5% |
| 2 | $65.00 | 1,319 | $86K | 4.5% |
| Total | $65.00 avg | 29,539 | $1.9M | 100% |
| Filing → |
| EBS | SELL | 2018-09-06 | $5.5M | — | Filing → |
| EBS | SELL | 2018-06-07 | $823K | — | Filing → |
| EBS | SELL | 2018-01-04 | $1.0M | — | Filing → |